Results 151 to 160 of about 2,550,423 (184)

Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study. [PDF]

Blood Neoplasia
Barragán E, Gil JV, Ayala R, Chillón C, Soria E, Bilbao C, Larráyoz MJ, Prados de la Torre E, Solana A, Martínez-Cuadrón D, Rodríguez-Veiga R, Rodríguez-Arbolí E, Tormo M, Martínez P, Lavilla E, García-Garay MC, Arce O, Bergua J, Serrano J, Botella C, Lacalzada C, Almela-Gallego A, Lopez-Lorenzo JL, Valero M, Ibañez F, Foncillas MÁ, Rodriguez-Medina C, Olave M, Gómez-Correcha KG, Calderón MT, Bernal T, Labrador J, Oliva A, Madrigal MD, Hermosín L, Amador L, García-Belmonte D, Herrera P, Vives S, Perez-Encinas M, Algarra L, Casado S, Martínez-Chamorro C, Polo M, Balerdi A, Roldán A, Couto C, Pereiro M, Vanegas R, Llop M, Sargas C, Cionfrini A, Mendizábal Y, Sánchez J, Calasanz MJ, Gómez-Casares MT, Pérez-Simón JA, García-Sanz R, Martínez-López J, Montesinos P, PETHEMA group.   +60 more
europepmc   +1 more source

HIV-1 APOBEC-context Mutations Detected by Next-Generation Sequencing in Plasma: Implications for Drug Resistance Interpretation. [PDF]

J Infect Dis
Illescas-López M, Muñoz Báez P, de Salazar A, Delgado R, Iborra A, Galán JC, Carracedo R, Sigcha M, López-Causape C, Fuentes A, Aguilera A, Marco-Sánchez C, García F, CoRIS .   +13 more
europepmc   +1 more source

Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk. [PDF]

Cancers (Basel)
Prats-Martín C, Pérez Ortega L, Molinos Quintana Á, Ribera J, Chiclana Rodríguez B, Caballero-Velázquez T, Carrillo Cruz E, Andrade-Ruiz HA, Garrastazul Sánchez MP, Madrigal Toscano MD, Solé Rodríguez M, Gómez Rosa M, Pérez-Simón JA, Morales-Camacho RM.   +13 more
europepmc   +1 more source

Validation and Exploratory Refinement of the HFA-ICOS Score for Cardiovascular Risk in Proteasome Inhibitor-Treated Multiple Myeloma: Single-Center Retrospective Study. [PDF]

Cancers (Basel)
Pons-Fuster E, Riquelme-Perez A, Shumbar V, González-Ponce CM, Fernandez-Avila JJ, Ramón-Martínez A, Moreno-Belmonte MJ, Cabañas-Perianes V, Pascual-Figal D, Diaz-Carrasco MS, Caro-Martínez C.   +10 more
europepmc   +1 more source

Clinical and Pharmacogenetic Factors Associated with Response to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Real-World Study of <i>JAK1</i>, <i>JAK2</i>, and <i>JAK3</i> Gene Variants. [PDF]

Pharmaceutics
Roldán AM, Márquez Pete N, Sánchez Suárez MDM, Rojo Tolosa S, Jiménez Morales A.   +4 more
europepmc   +1 more source

Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases. [PDF]

Pharmacol Res Perspect
Larrosa-García M, Pamplona IA, Tolosa SR, Morales AJ, Martínez MTS, Gallo MM, Colobran R, Vicente HG, Pena NM, Macías RPB, Ronsano JBM.   +10 more
europepmc   +1 more source

Secretory carcinoma of the breast: a report of six cases with different immunophenotypes and molecular subtypes. [PDF]

Histopathology
López-García MÁ, Galán L, Meléndez B, Eizaguirre B, Masero JM, Biscuola M, Benavent M, Vieites B.   +7 more
europepmc   +1 more source

Territorial inequities in access to essential medicines for neglected tropical diseases in a decentralised European health system: a nationwide assessment in Spain. [PDF]

Infect Dis Poverty
Belhassen-García M, de la Calle-Prieto F, Del Moral Sánchez JM, Alonso-Sardón M, Ayuso-Garcia B, Blanco JR, Bustos Morell C, Campany-Herrero D, Carranza C, Ercilla Liceaga M, Garcia López-Hortelano M, García-Vázquez E, Garrido B, Hernandez Cabrera M, Ibero C, Illaro Uranga A, Jimenez Núñez C, Kortajarena Urkola X, Lapeña J, Llenas-García J, López-Vizcaíno A, Losada-Galvan I, Merino P, Moreno Á, Mulet AM, Navarro M, Pardo Lledías J, Perez-Molina JA, Periañez Parraga L, Picazo Sanchís G, Pozo Rosado L, Praena-Segovia J, Salas-Coronas J, Salvador F, Urda-Romacho J, Romay-Barja M.   +35 more
europepmc   +1 more source